- Home
- LTRX vs VOR Comparison
LTRX vs VOR Comparison
Compare LTRX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRX
- VOR
- Stock Information
- Founded
- LTRX 1989
- VOR 2015
- Country
- LTRX United States
- VOR United States
- Employees
- LTRX N/A
- VOR N/A
- Industry
- LTRX Computer Communications Equipment
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- LTRX Telecommunications
- VOR Health Care
- Exchange
- LTRX Nasdaq
- VOR Nasdaq
- Market Cap
- LTRX 106.5M
- VOR 85.7M
- IPO Year
- LTRX 2000
- VOR 2021
- Fundamental
- Price
- LTRX $2.10
- VOR $0.15
- Analyst Decision
- LTRX Strong Buy
- VOR Buy
- Analyst Count
- LTRX 5
- VOR 7
- Target Price
- LTRX $5.60
- VOR $7.83
- AVG Volume (30 Days)
- LTRX 216.2K
- VOR 1.2M
- Earning Date
- LTRX 05-08-2025
- VOR 05-20-2025
- Dividend Yield
- LTRX N/A
- VOR N/A
- EPS Growth
- LTRX N/A
- VOR N/A
- EPS
- LTRX N/A
- VOR N/A
- Revenue
- LTRX $143,159,000.00
- VOR N/A
- Revenue This Year
- LTRX N/A
- VOR N/A
- Revenue Next Year
- LTRX $11.33
- VOR N/A
- P/E Ratio
- LTRX N/A
- VOR N/A
- Revenue Growth
- LTRX N/A
- VOR N/A
- 52 Week Low
- LTRX $1.91
- VOR $0.15
- 52 Week High
- LTRX $4.55
- VOR $1.87
- Technical
- Relative Strength Index (RSI)
- LTRX 42.72
- VOR 14.55
- Support Level
- LTRX $2.10
- VOR $0.65
- Resistance Level
- LTRX $2.30
- VOR $0.85
- Average True Range (ATR)
- LTRX 0.12
- VOR 0.07
- MACD
- LTRX 0.03
- VOR -0.05
- Stochastic Oscillator
- LTRX 23.08
- VOR 2.67
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.